Browse Data and Analysis

Tunisia is continuing to postpone non-urgent matters in front of major political and economic reforms. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.

With the notable exception of Bt. cotton, biotech products are not allowed to be produced, imported, or marketed in Kenya. On October 30, 2024, Kenya’s High Court is expected to make a ruling on the biotechnology case challenging the production and trade in genetically engineered (GE) agricultural products.